Pancreatic adenocarcinoma

Liposomal irinotecan, oxaliplatin, and S-1 as first-line therapy for patients with locally advanced or metastatic pancreatic adenocarcinoma (NASOX): A multicenter phase I/IIa study

Jeong H, Kim BJ, Lee CK, Park I, Zang DY, Choi HJ, Lee SS, Park DH, Song TJ, Oh D, Moon SH, Kim KP, Wainberg[...]

By sjmartinez • July 7, 2024

Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review

Dayyani F, Macarulla T, Johnson A, Wainberg ZA. Second-line treatment options for patients with metastatic pancreatic ductal adenocarcinoma: A systematic literature review. Cancer Treat Rev.[...]

By sjmartinez • February 8, 2023